Related Experiment Video
Updated: Dec 24, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
The MID1 gene product in physiology and disease
Rossella Baldini1, Martina Mascaro1, Germana Meroni1
1Department of Life Sciences, University of Trieste, Trieste, Italy.
Abstract:
MID1 is an E3 ubiquitin ligase of the Tripartite Motif (TRIM) subfamily of RING-containing proteins, hence also known as TRIM18. MID1 is a microtubule-binding protein found in complex with the catalytic subunit of PP2A (PP2Ac) and its regulatory subunit alpha 4 (α4). To date, several substrates and interactors of MID1 have been described, providing evidence for the involvement of MID1 in a plethora of essential biological processes, especially during embryonic development. Mutations in the MID1 gene are responsible of the X-linked form of Opitz syndrome (XLOS), a multiple congenital disease characterised by defects in the development of midline structures during embryogenesis. Here, we review MID1-related physiological mechanisms as well as the pathological implication of the MID1 gene in XLOS and in other clinical conditions.
Insights
The MID1 protein (also known as TRIM18) is crucial for embryonic development and cell processes. Mutations in the MID1 gene cause X-linked Opitz syndrome, a congenital disorder affecting midline structure development.
Area of Science:
- Molecular Biology
- Developmental Biology
- Genetics
Background:
- MID1 (TRIM18) is an E3 ubiquitin ligase and microtubule-binding protein.
- MID1 forms a complex with PP2A (PP2Ac) and alpha 4 (α4) regulatory subunit.
- MID1 participates in numerous biological processes, particularly during embryonic development.
Purpose of the Study:
- To review the physiological roles of MID1.
- To discuss the pathological implications of MID1 gene mutations.
- To explore MID1's involvement in X-linked Opitz syndrome (XLOS) and other conditions.
Main Methods:
- Literature review of MID1 functions and associated diseases.
- Analysis of MID1 substrates and interactors.
- Examination of genetic mutations in MID1.
Main Results:
- MID1's involvement in essential biological processes is supported by identified substrates and interactors.
- MID1 mutations are directly linked to X-linked Opitz syndrome (XLOS).
- MID1 plays a role in the development of midline structures.
Conclusions:
- MID1 is vital for normal embryonic development.
- Dysregulation of MID1 function leads to congenital abnormalities like XLOS.
- Further research into MID1 mechanisms can inform treatment strategies for related disorders.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Pleiotropy
Master Transcription Regulators
Abnormal Proliferation
Hedgehog Signaling Pathway
Incomplete Dominance

